Galectin Therapeutics
GALT
GALT
77 hedge funds and large institutions have $19M invested in Galectin Therapeutics in 2020 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 17 increasing their positions, 21 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
19% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 21
34% less capital invested
Capital invested by funds: $28.8M → $19M (-$9.81M)
Holders
77
Holding in Top 10
–
Calls
$321K
Puts
$208K
Top Buyers
| 1 | +$79.3K | |
| 2 | +$53.4K | |
| 3 | +$52.4K | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
+$44.6K |
| 5 |
Two Sigma Investments
New York
|
+$33K |
Top Sellers
| 1 | -$255K | |
| 2 | -$212K | |
| 3 | -$174K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$98.6K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$80K |